Results 31 to 40 of about 51,706 (265)

3‐Deoxy‐3‐Fluoro Mannuronic Acid Alginates: Stereoselective Automated Synthesis and Conformational Behaviour

open access: yesAngewandte Chemie, EarlyView.
The impact of C‐3 fluorination on the synthesis and conformation of alginate oligosaccharides is investigated. A C‐3‐fluoro mannuronic acid building block is generated and shown to react with high β‐selectivity. Automated glycan assembly enables access to uniquely fluorinated mannuronic acid alginates where deoxyfluorination is shown not to perturb the
Sean T. Evans   +10 more
wiley   +2 more sources

Research progress on pulmonary aspergillosis in patients with bronchiectasis [PDF]

open access: yesXin yixue, 2022
Bronchiectasis is a chronic inflammatory disease of the airway in which one or more proximal bronchi (diameter greater than 2 mm) are irreversibly dilated caused by a variety of causes.
Wang Shixiong, Zhang Haochuan, Li You, Deng Zhenkai, Huang He
doaj   +1 more source

Increased mortality in patients with non cystic fibrosis bronchiectasis with respiratory comorbidities

open access: yesScientific Reports, 2021
There are limited data regarding whether mortality is higher in patients with non cystic fibrosis bronchiectasis (bronchiectasis) than in those without bronchiectasis.
Hayoung Choi   +18 more
doaj   +1 more source

How are the ancient cystic fibrosis patients? Cystic fibrosis diagnosed over 60 years-old

open access: yesRespiratory Medicine Case Reports, 2017
Background and aims: To specify the prevalence of patients diagnosed with CF at age of ≥60 year-old and to analyze their characteristics. Patients and methods: Observational study of CF patients which were diagnosed at age ≥60 year-old.
C. Prados   +10 more
doaj   +1 more source

Endotypes in bronchiectasis: moving towards precision medicine. A narrative review.

open access: yesPulmonology, 2023
Bronchiectasis is a highly complex entity that can be very challenging to investigate and manage. Patients are diverse in their aetiology, symptoms, risk of complications and outcomes. "Endotypes"- subtypes of disease with distinct biological mechanisms,
M. Martins, H. Keir, J. Chalmers
semanticscholar   +1 more source

Outcome and prognostic factors after lung transplantation for bronchiectasis other than cystic fibrosis

open access: yesBMC Pulmonary Medicine, 2021
Background While lung transplant (LTX) can be an effective therapy to provide the survival benefit in selected populations, post-transplant outcome in LTX recipients with bronchiectasis other than cystic fibrosis (CF) has been less studied.
Takashi Hirama   +6 more
doaj   +1 more source

The prevalence of bronchiectasis in patients with alpha-1 antitrypsin deficiency: initial report of EARCO

open access: yesOrphanet Journal of Rare Diseases, 2023
Background Although bronchiectasis has been recognised as a feature of some patients with Alpha1-Antitrypsin deficiency the prevalence and characteristics are not widely known.
R. Stockley   +25 more
semanticscholar   +1 more source

Bronchiectasis and increased mortality in patients with corticosteroid-dependent severe asthma: a nationwide population study

open access: yesTherapeutic Advances in Respiratory Disease, 2020
Background: Long-term corticosteroid (CS) use is associated with increased mortality in patients with asthma, and comorbid bronchiectasis is also associated with frequent asthma exacerbation and increased healthcare use.
Hayoung Choi   +7 more
doaj   +1 more source

Bronchiectasis-associated hospitalizations in Germany, 2005-2011: a population-based study of disease burden and trends. [PDF]

open access: yesPLoS ONE, 2013
BACKGROUND: Representative population-based data on the epidemiology of bronchiectasis in Europe are limited. The aim of the present study was to investigate the current burden and the trends of bronchiectasis-associated hospitalizations and associated ...
Felix C Ringshausen   +5 more
doaj   +1 more source

Global prevalence of non-tuberculous mycobacteria in adults with non-cystic fibrosis bronchiectasis 2006–2021: a systematic review and meta-analysis

open access: yesBMJ Open, 2022
Objective To accurately estimate the global prevalence of non-tuberculous mycobacteria (NTM) in adults with non-cystic fibrosis (non-CF) bronchiectasis and to determine the proportion of NTM species and subspecies in clinical patients from 2006 to 2021 ...
Yunchun Zhou   +4 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy